How many 8-K filings has Anika Therapeutics, Inc. filed?

Anika Therapeutics, Inc. (ANIK) has 9 8-K (Current Event Report) filings on record, spanning Feb 2024 to Jun 2025.

What is a 8-K filing?

A 8-K is an SEC filing known as "Current Event Report." Filed to announce significant events or material changes such as acquisitions, executive departures, earnings announcements, or bankruptcy filings.

Where can I read Anika Therapeutics, Inc. 8-K filings in plain English?

ReadTheFiling provides AI-powered plain-English summaries of all Anika Therapeutics, Inc. 8-K filings, including risk assessment, sentiment analysis, and key financial figures.

Anika Therapeutics, Inc. (ANIK) — 8-K Filings

All 8-K filings from Anika Therapeutics, Inc.. Browse 9 Current Event Report reports with AI-powered summaries and risk analysis.

8-K Filings (9)

Anika Therapeutics Files 8-K on Officer/Director Changes & More — Jun 24, 2025 Risk: medium
Anika Therapeutics, Inc. filed an 8-K on June 24, 2025, reporting events that occurred on June 20, 2025. The filing covers the departure of directors or certain
Anika Therapeutics Reports Officer and Director Changes — Apr 10, 2025 Risk: medium
Anika Therapeutics, Inc. filed an 8-K on April 10, 2025, reporting events as of April 4, 2025. The filing covers the departure of directors or certain officers,
Anika Therapeutics Files 8-K on Financials — Mar 12, 2025 Risk: low
Anika Therapeutics, Inc. filed an 8-K on March 12, 2025, reporting on its results of operations and financial condition. The filing also includes financial stat
Anika Therapeutics Completes Asset Acquisition — Mar 11, 2025 Risk: medium
Anika Therapeutics, Inc. announced the completion of its acquisition of certain assets from a third party on March 7, 2025. The filing also includes financial s
Anika Therapeutics Files 8-K on Financials — Oct 31, 2024 Risk: low
Anika Therapeutics, Inc. filed an 8-K on October 31, 2024, reporting on its results of operations and financial condition. The filing includes financial stateme
Anika Therapeutics Reports on Shareholder Votes — Jul 11, 2024 Risk: low
Anika Therapeutics, Inc. filed an 8-K on July 11, 2024, reporting on matters submitted to a vote of security holders on July 9, 2024. The filing details the com
Anika Therapeutics Appoints New Chief Medical Officer — May 28, 2024 Risk: low
Anika Therapeutics, Inc. announced on May 28, 2024, the appointment of Dr. Charles L. ("Chip") Wilson as Chief Medical Officer. Dr. Wilson brings extensive expe
Anika Therapeutics Files 8-K on Financials — Mar 13, 2024 Risk: low
Anika Therapeutics, Inc. filed an 8-K on March 13, 2024, reporting on its results of operations and financial condition. The filing includes financial statement
Anika Therapeutics Reports Officer Compensation Changes, Board Updates — Feb 26, 2024 Risk: low
Anika Therapeutics, Inc. (NASDAQ: ANIK) filed an 8-K on February 26, 2024, reporting events that occurred on February 24, 2024. The filing primarily concerns ch

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX